This inventor holds 1 USPTO granted patent, plus 2 CIPO patents. Top assignee: Innate Pharma, S.a.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Renaud Buffet: Innovator in Hematological Treatments
Introduction
Renaud Buffet is a notable inventor based in Vanves, France. He has made significant contributions to the field of hematology through his innovative research and development of treatment methods for recurrent hematological malignancies.
Latest Patents
Renaud Buffet holds a patent for "Methods for treatment of recurrent hematological malignancies." This patent includes compositions comprising compounds that neutralize NK cell inhibitory receptors and methods of using such compositions in the treatment of hematological malignancies. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Renaud Buffet is associated with Innate Pharma, S.A., a company dedicated to developing innovative immunotherapies for cancer treatment. His work at Innate Pharma has positioned him as a key player in the fight against hematological diseases.
Collaborations
Throughout his career, Renaud has collaborated with esteemed colleagues such as Pascale Andre and Marcel Rozencweig. These partnerships have further enhanced his research and contributed to the development of effective treatment strategies.
Conclusion
Renaud Buffet's contributions to the field of hematology through his innovative patent and collaborations highlight his dedication to improving patient outcomes. His work continues to inspire advancements in cancer treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile